NEW YORK, Aug. 09, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. ( &#34;Praxis&#34; or the &#34;Company&#34; ) PRAX. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

PRAX

<p>NEW YORK, Aug. 09, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. ( "Praxis" or the "Company" ) PRAX. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.</p>

投资者警示：Pomerantz 律师事务所正在代表 Praxis Precision Medicines, Inc.的投资者进行索赔调查